Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News 23andMe Holding Co. ME

Consumer Cyclical Healthcare Advertising Agencies
23andMe Holding Co. is a genetics-led consumer healthcare and biopharmaceutical company. The Company operates through two segments: Consumer & Research Services and Therapeutics. The Consumer & Research Services business segment comprises its Personal Genome Service (PGS), telehealth business, and research service. PGS services provide customers with a broad suite of genetic reports, including... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ME)

23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador's Precision Medicines for Immunology & Inflammation

GlobeNewswire 1 day ago

23andMe Reports Second Quarter Fiscal Year 2025 Financial Results

GlobeNewswire 9 days ago

23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future

GlobeNewswire 9 days ago

CORRECTION - 23andMe to Report Q2 FY2025 Financial Results

GlobeNewswire 13 days ago

23andMe to Report Q2 FY2025 Financial Results

GlobeNewswire November 7, 2024

23andMe Regains Compliance With Nasdaq Listing Requirements

GlobeNewswire October 30, 2024

23andMe Appoints Three New Independent Directors to Board

GlobeNewswire October 29, 2024

23andMe Introduces New Feature Helping African Americans Trace Their Roots to Post Slavery Communities in the South

GlobeNewswire October 17, 2024

23andMe Announces Completion of 1-for-20 Reverse Stock Split

GlobeNewswire October 16, 2024
View More News ››

Opinion & Analysis (NDAQ:ME)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ME)

23andMe Introduces New Feature Helping African Americans Tra

JUST IN: $ME 23andMe Introduces New Feature Helping African Americans Trace Their Roots to Post Slavery Communities in the...
whytestocks - October 17, 2024

Barrack, Rodos & Bacine Is Investigating 23andMe Holding Co.

Breaking News: $ME Barrack, Rodos & Bacine Is Investigating 23andMe Holding Co.PHILADELPHIA, PA / ACCESSWIRE / September 23, 2024...
whytestocks - September 23, 2024

One of the Largest and Most Diverse Studies on Sickle Cell T

Just In: $ME One of the Largest and Most Diverse Studies on Sickle Cell Trait and Blood Clots Reveals Findings That Impact All...
whytestocks - September 12, 2024

Once Valued At Billions, 23andMe's CEO Considers Privatizati

News; $ME Once Valued At Billions, 23andMe's CEO Considers Privatization To Secure Company's Future | BenzingaAnne Wojcicki, co...
whytestocks - April 18, 2024

DNA Profile

Big Brother: "We need a way for every citizen to give us their DNA profile." Little Brother: "There's no way. These...
IgnacioCashmere - February 13, 2024

Is 23andMe Stock a Smart Buy Right Now?

Just In: $ME Is 23andMe Stock a Smart Buy Right Now?2024-02-13 09:53:00 ET Genetic-testing company 23andMe (NASDAQ: ME) is a household...
whytestocks - February 13, 2024
View more Bullboard ››

GMV Minerals Inc

GMV Minerals Inc

GMV Minerals Inc. is an exploration company focused on developing precious metal assets in Arizona. The Company, through its ...
View More »